Correlation Between Incyte and Ginkgo Bioworks
Can any of the company-specific risk be diversified away by investing in both Incyte and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incyte and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incyte and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Incyte and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incyte with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incyte and Ginkgo Bioworks.
Diversification Opportunities for Incyte and Ginkgo Bioworks
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Incyte and Ginkgo is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Incyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incyte are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Incyte i.e., Incyte and Ginkgo Bioworks go up and down completely randomly.
Pair Corralation between Incyte and Ginkgo Bioworks
Given the investment horizon of 90 days Incyte is expected to under-perform the Ginkgo Bioworks. But the stock apears to be less risky and, when comparing its historical volatility, Incyte is 3.34 times less risky than Ginkgo Bioworks. The stock trades about -0.07 of its potential returns per unit of risk. The Ginkgo Bioworks Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 874.00 in Ginkgo Bioworks Holdings on December 19, 2024 and sell it today you would lose (126.00) from holding Ginkgo Bioworks Holdings or give up 14.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Incyte vs. Ginkgo Bioworks Holdings
Performance |
Timeline |
Incyte |
Ginkgo Bioworks Holdings |
Incyte and Ginkgo Bioworks Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Incyte and Ginkgo Bioworks
The main advantage of trading using opposite Incyte and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incyte position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Ginkgo Bioworks vs. Ocean Biomedical | Ginkgo Bioworks vs. Enveric Biosciences | Ginkgo Bioworks vs. Hepion Pharmaceuticals | Ginkgo Bioworks vs. Elevation Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |